Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Decreases By 44.4%

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 2,500 shares, a decrease of 44.4% from the March 15th total of 4,500 shares. Based on an average daily trading volume, of 20,400 shares, the short-interest ratio is presently 0.1 days.

Apollomics Stock Down 6.5 %

Shares of NASDAQ APLMW opened at $0.01 on Wednesday. Apollomics has a 1-year low of $0.01 and a 1-year high of $0.03. The business’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.01.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.